机构：[1]Department of Anesthesiology, the Third Hospital of Hebei Medical University, Shijiazhuang, Hebei 050051, China.[2]Hebei Provincial Cancer Institute, Shijiazhuang, Hebei 050011, China.临床科室河北省肿瘤研究所河北医科大学第四医院[3]Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang, Hebei 050021, China.
出处：
ISSN：
摘要：
The microbial community is present abundantly in mucosal organs including the intestine, the oral cavity, and the vagina, and is referred to as the microbiota. The microbiota is composed of commensal bacteria and other microorganisms. Intestinal colonization by commensal microorganisms is essential for host physiological functions from the maintenance of barrier homeostasis locally to the regulation of metabolism, hematopoiesis, inflammation, immune development, and other functions systemically. Evidence is growing that the gut microbiota can modulate the host response to cancer immunotherapy. In this review, we discuss the evidence for the ability of the microbiota to modulate immunotherapy, their mechanisms of action, and the possibility of altering the microbiota to improve immunotherapy efficacy.
语种：
外文
PubmedID：
中科院分区：
出版当年[2019]版：
大类|4 区医学
小类|4 区医学：研究与实验
最新[2025]版：
大类|4 区医学
小类|4 区医学：研究与实验
第一作者：
第一作者机构：[1]Department of Anesthesiology, the Third Hospital of Hebei Medical University, Shijiazhuang, Hebei 050051, China.
推荐引用方式(GB/T 7714)：
Huo Shuping,Liu Liang,Liu Jianghui,et al.Modulation of cancer immunotherapy efficacy by gut microbiota[J].Discovery Medicine.2019,27(147):93-100.
APA：
Huo Shuping,Liu Liang,Liu Jianghui,Li Qiaomin&Wang Jing.(2019).Modulation of cancer immunotherapy efficacy by gut microbiota.Discovery Medicine,27,(147)
MLA：
Huo Shuping,et al."Modulation of cancer immunotherapy efficacy by gut microbiota".Discovery Medicine 27..147(2019):93-100
